MALAT1 and hepatocellular carcinoma: Taken together, inhibition of MALAT1 showed converse phenotypes observed with mascRNA overexpression both in vitro and in vivo, suggesting that lncRNA MALAT1 and its derived mascRNA have similar functions in promoting HCC.